CIA
EXAS

Caerus Investment Advisors’s Exact Sciences EXAS Stock Holding History

Caerus Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,638
Closed -$573K – 312
2025
Q4 		$573K Buy
+5,638
New +$453K 0.19% 122

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Caerus Investment Advisors's EXAS Position: Q1 2026 in Review

Caerus Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,638 shares — an estimated $573K sold.

Caerus Investment Advisors first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $573K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Caerus Investment Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Caerus Investment Advisors sold 5,638 Exact Sciences shares in Q1 2026, an estimated $573K.
  • Caerus Investment Advisors first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Caerus Investment Advisors's Exact Sciences position peaked at $573K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.